日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
2018/12/07 | 07 : 10 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
2018/12/07 | 06 : 18 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
2018/12/05 | 07 : 53 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
2018/12/05 | 07 : 49 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
2018/11/14 | 07 : 02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
2018/11/14 | 07 : 01 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
2018/11/14 | 07 : 00 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
2018/11/14 | 06 : 59 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
2018/11/10 | 07 : 09 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
2018/11/10 | 06 : 19 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
2018/11/10 | 06 : 17 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
2018/10/31 | 05 : 32 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
2018/10/27 | 05 : 59 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
2018/10/27 | 05 : 18 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
2018/10/25 | 06 : 04 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
2018/10/25 | 06 : 04 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
2018/10/03 | 05 : 57 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
2018/09/26 | 06 : 02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
2018/09/26 | 06 : 01 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
2018/09/26 | 06 : 00 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
2018/09/26 | 05 : 59 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
2018/09/25 | 05 : 20 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
2018/09/19 | 05 : 57 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
2018/09/05 | 05 : 46 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
2018/08/17 | 20 : 01 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
2018/08/15 | 06 : 06 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
2018/08/15 | 06 : 00 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
2018/08/08 | 06 : 04 | Edgar (US Regulatory) | Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
2018/08/04 | 06 : 22 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
2018/08/04 | 05 : 18 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |